Welcome to our dedicated page for Nuburu SEC filings (Ticker: BURU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The physics of blue-laser welding can make even seasoned analysts pause, and NUBURU’s 10-K is packed with lab-grade detail on optics, patent counts, and supply-chain risks most filings never touch. If you have ever typed “Nuburu insider trading Form 4 transactions” or “How do I find a Nuburu quarterly earnings report 10-Q filing?” you know the search can be time-consuming. Stock Titan solves that problem in seconds.
Our AI engine reads every new document the moment it hits EDGAR, then delivers plain-language answers to questions like “understanding Nuburu SEC documents with AI” or “Nuburu 8-K material events explained.” Skip the 300-page PDF and open a concise brief that pinpoints R&D spending trends, spatter-free copper-welding breakthroughs, and customer concentration risks. Need governance data? We link directly to the Nuburu proxy statement executive compensation table. Watching ownership moves? Receive real-time alerts on Nuburu Form 4 insider transactions real-time and track every Nuburu executive stock transactions Form 4 filing.
Whether you want a Nuburu annual report 10-K simplified for big-picture strategy, a Nuburu earnings report filing analysis to compare quarter-over-quarter laser sales, or fast notice when an 8-K announces a material supplier agreement, Stock Titan delivers. Investors use these insights to monitor patent pipeline progress, gauge capital needs for new laser fabs, and benchmark margins against other industrial-tech issuers. All filings, all forms, updated live—explained simply so you can act with confidence.
Nuburu, Inc. files an S-1 describing its Business Combination with Legacy Nuburu and material financing activity in 2025. The company issued multiple unsecured convertible notes to investors including Indigo Capital, Brick Lane, Bomore, Torcross, Diagonal and Boot with face amounts such as $1,578,495, $1,421,053, $2,108,523, $225,000 and others, many issued for capital infusions or to extinguish prior debt. Convertible instruments could convert into tens of millions of shares (38,276,895 shares assumptive conversion as of Aug 20, 2025), creating substantial dilution. The filing discloses a Notice of Noncompliance from NYSE American, prior restatements and identified material weaknesses in internal controls, and significant asset write-downs (inventory and property at leased premises written to zero in Q1 2025). The prospectus highlights extensive risk factors related to financing, commercialization, acquisitions, regulatory and operational risks and governance provisions that limit stockholder actions.
Nuburu, Inc. reported substantial non-cash impairments and financing activity in the quarter. Management wrote inventory to a net realizable value of $0, fully impaired property and equipment at a leased location, and fully impaired the related operating lease right-of-use asset, recording those losses in the condensed consolidated statement of operations for the six months ended June 30, 2025. The company recorded certain financial instruments at fair value using Level 3 inputs and determined its Public Warrants had no value as of June 30, 2025. The NYSE American notified the company that it was not in compliance with continued listing standards, although trading remains ongoing under the symbol BURU with a noncompliance designation. The company completed multiple convertible note financings and other capital infusions (including Indigo Capital, Brick Lane, Bomore, Diagonal, Boot and others) with varying terms, conversion prices tied to VWAP metrics, and several high-cost notes (for example, an Agile Note bearing 44% interest). The company entered a SEPA commitment providing access to up to $100 million of Common Stock sales and issued 1,332,623 commitment-fee shares during Q2 2025. Significant preferred stock remeasurement increased a mandatorily redeemable liability to $23,889,050, generating a $10,398,050 adjustment to net loss available to common shareholders for the six months ended June 30, 2025.